Denali Therapeutics Inc. DNLI Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s common stock?
- Denali Therapeutics Inc. (DNLI) reported common stock of $1.91M in Q1 2026.
- How has Denali Therapeutics Inc.'s common stock changed year-over-year?
- Denali Therapeutics Inc.'s common stock increased by 7.6% year-over-year, from $1.78M to $1.91M.
- What is the long-term trend for Denali Therapeutics Inc.'s common stock?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s common stock has grown at a 4.3% compound annual growth rate (CAGR), from $1.53M to $1.89M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).